Our results and a recent paper30 both show that the sensitivity of CRC cells to BETi is correlated with inhibition rate of c-myc expression, indicating that c-myc downregulation is the primary mechanism to inhibit tumor growth by BETi in CRC. The gene discussed is MYC; the disease is neoplasm.